Join to View Full Profile
26025 Lahser Rd2nd FloorSouthfield, MI 48033
Phone+1 248-663-1900
Fax+1 248-663-1902
Dr. Shapiro is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of California (San Francisco)Fellowship, Hand Surgery (Orthopaedic Surgery), 1996 - 1997
Mount Sinai Medical Center of ClevelandResidency, Orthopaedic Surgery, 1991 - 1996
Wayne State University School of MedicineClass of 1991
Certifications & Licensure
CA State Medical License 1996 - Present
MI State Medical License 1981 - 2026
OH State Medical License 1994 - 1996
American Board of Orthopaedic Surgery Orthopaedic Surgery- American Board of Orthopaedic Surgery Surgery of the Hand
National Board of Physicians and Surgeons Orthopaedic Surgery- National Board of Physicians and Surgeons Surgery of the Hand
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification SRS EHR, SRSsoft, 2013
- Super Doctor SuperDoctors.com
Publications & Presentations
PubMed
- Suture Fixation of Subacute Pediatric Seymour Fractures.Ethan Graham Englert, Trevor Tooley, Kevin Weisz, Paul Shapiro
Journal of Hand Surgery Global Online. 2023-03-01 - 6 citationsMeniscal allograft arthroplasty for the treatment of trapeziometacarpal arthritis of the thumb.Paul S. Shapiro, Edward Diao, Lynn M. Givens
Hand. 2015-01-22 - 235 citationsInternal tandem duplication of FLT3 (FLT3/ITD) induces increased ROS production, DNA damage, and misrepair: implications for poor prognosis in AML.Annahita Sallmyr, Jinshui Fan, Kamal Datta, Kyu-Tae Kim, Dan Grosu
Blood. 2008-03-15
Grant Support
- Optimizing function-selective ERK1/2 inhibitors for reducing AP-1-mediated airway pathology in asthma.UNIVERSITY OF MARYLAND BALTIMORE2023–2025
- Substrate Specific ERK Docking Domain InhibitorsNational Cancer Institute2006–2010
- Development Of ERK Docking Domain InhibitorsNational Cancer Institute2004–2005
- MAPK Pathway Regulation Of Myeloid Cell DifferentiationNational Institute Of General Medical Sciences1996–1998
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
